Effects of rosuvastatin on fasting and postprandial lipoprotein and fatty acid metabolism in combined hyperlipidemic male patients with premature coronary sclerosis.

Autor: van Oostrom, A., Plokker, T., Cabezas, M. C.
Zdroj: International Journal of Clinical Practice (Supplement); Jun2005 Supplement 148, Vol. 59, p3-13, 11p
Abstrakt: The article presents the abstract of the study conducted by researcher A. van Oostrom and colleagues, who investigated the effects of rosuvastatin on postprandial lipoprotein and fatty acid metabolism in 20 male premature coronary artery disease (CAD) patients. Self-determined daylong capillary triglycerides (TGc) were measured off-treatment and after rosuvastatin 20 and 40 mg per day. In combined hyperlipidemic patients with premature CAD, rosuvastatin improves postprandial fatty acid and lipoprotein metabolism, the latter by strongly reducing the cholesterol content of TG-rich lipoproteins.
Databáze: Supplemental Index